![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/INDRAMEDCO.png)
Share the post "Indraprastha Medical Corporation ‘s Q3 2024-25 Latest News: Profit Rises by 11.45% YoY"
Highlights
🔹 The presented financial data is Standalone to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 6.03 % in the past year, decrease in net sales/revenue by -7.12 %. 🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 20.14 %. Marginal decrease of -15.21% in other income during this quarter. 🔹 Profit over the Year and quarter: Significant improvement in profitability for Indraprastha Medical Corporation Limited. Notable increase of 11.45 % in net profit Year to Year, Indraprastha Medical Corporation Limited’s profitability dropped by -22.62 % Quarter to Quarter. 🔹 EPS over the Year and quarter: EPS increased by 11.53 % Year to Year. EPS decreased by -22.68 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 306.46 Cr | Rs. 349.82 Cr | Rs. 324.93 Cr | -7.12 % | + 6.03 % |
| Expenses | Rs. 259.16 Cr | Rs. 286.18 Cr | Rs. 272.74 Cr | -4.7 % | + 5.24 % |
| Operating Profit | Rs. 47.3 Cr | Rs. 63.64 Cr | Rs. 52.19 Cr | -17.99 % | + 10.34 % |
| OPM % | 15.43 % | 18.19 % | 16.06 % | -2.13 % | + 0.63 % |
| Other Income | Rs. 4.27 Cr | Rs. 6.05 Cr | Rs. 5.13 Cr | -15.21 % | + 20.14 % |
| Interest | Rs. 0.87 Cr | Rs. 1.59 Cr | Rs. 1.58 Cr | -0.63 % | + 81.61 % |
| Depreciation | Rs. 10.03 Cr | Rs. 11.17 Cr | Rs. 11.21 Cr | + 0.36 % | + 11.76 % |
| Profit before tax | Rs. 40.67 Cr | Rs. 56.93 Cr | Rs. 44.53 Cr | -21.78 % | + 9.49 % |
| Tax % | 27.61 % | 25.52 % | 26.32 % | + 0.8 % | -1.29 % |
| Net Profit | Rs. 29.44 Cr | Rs. 42.4 Cr | Rs. 32.81 Cr | -22.62 % | + 11.45 % |
| EPS in Rs | Rs. 3.21 | Rs. 4.63 | Rs. 3.58 | -22.68 % | + 11.53 % |
Today, we’re looking at Indraprastha Medical Corporation Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 6.03 %. However, it did see a marginal slip of -7.12 % from the previous quarter. Expenses decreased slightly by -4.7 % quarter-on-quarter, aligning with the annual rise of 5.24 %. Operating profit, while up 10.34 % compared to last year, faced a quarter-on-quarter dip of -17.99 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.63 %, but a shrinkage of -2.13 % sequentially. Other income fell by -15.21 % compared to the last quarter, despite an annual growth of 20.14 %. Interest expenses dropped significantly by -0.63 % from the previous quarter, yet the year-over-year increase remains at a moderate 81.61 %. Depreciation costs climbed by 0.36 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 11.76 %. Profit before tax grew annually by 9.49 % but saw a reduction from the preceding quarter by -21.78 %.
Tax expenses as a percentage of profits decreased slightly by -1.29 % compared to last year, with a more notable quarter-on-quarter increase of 0.8 %. Net profit rose by 11.45 % year-on-year but witnessed a -22.62 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 11.53 % but a quarterly fall of -22.68 %. In summary, Indraprastha Medical Corporation Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 306.46 Cr | Rs. 349.82 Cr | Rs. 324.93 Cr | -7.12 % | + 6.03 % |
| Expenses | Rs. 259.16 Cr | Rs. 286.18 Cr | Rs. 272.74 Cr | -4.7 % | + 5.24 % |
| Operating Profit | Rs. 47.3 Cr | Rs. 63.64 Cr | Rs. 52.19 Cr | -17.99 % | + 10.34 % |
| Net Profit | Rs. 29.44 Cr | Rs. 42.4 Cr | Rs. 32.81 Cr | -22.62 % | + 11.45 % |
| EPS in Rs | Rs. 3.21 | Rs. 4.63 | Rs. 3.58 | -22.68 % | + 11.53 % |
In reviewing Indraprastha Medical Corporation Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 6.03 % year-on-year growth, although there was a slight dip of -7.12 % from the previous quarter. Expenses rose by 5.24 % compared to the previous year, with a decrease of -4.7 % quarter-on-quarter. Operating Profit surged by 10.34 % annually, and saw a -17.99 % decrease from the last quarter.
Net Profit showed yearly increase of 11.45 %, and experienced a -22.62 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 11.53 % annually, however dipped by -22.68 % compared to the last quarter. In essence, while Indraprastha Medical Corporation Limited exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/ECORECO.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/DSINVEST.png)
